Retension Pharmaceuticals, Inc.

RTSN · Healthcare · Biotechnology

Market cap

$89.3M

P/E

—

Fwd P/E

—

Dividend yield

—

F-score

n/a

Altman Z

n/a

Beneish M

n/a

Dividend safety

n/a